Skip to main content
. 2021 Jan 25;10(1):75–92. doi: 10.1007/s40121-020-00395-2

Fig. 3.

Fig. 3

Prevalence of carbapenem-resistant Gram-negative infections in the United States.

Adapted from Cai et al. [38]. In the US, overall carbapenem resistance among the 4 selected pathogens (E. coli, K. pneumoniae, P. aeruginosa, A. baumannii) was 4.5% out of 292,742 isolates tested